Stock screenerAll disclosures →
EDGAR →
AMRX
Conviction 100HealthcareScan · Thu, Jun 25, 2026AMRX$17.30+0.17%
ResistanceSupportVol 14Insider sellVol MA14 2.51M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price17.30
Change+0.17%
Gap+0.78%
Rel volume3.43×
Avg volume2.29M
Avg $ vol35.34M
SMA 2015.02
SMA 5013.68
SMA 20012.53
Price vs 50+26.48%
Price vs 200+38.05%
MA stackbullish
50/200 cross—
Supertrendup · 15.75
RSI (14)82
MACD hist0.19
MACD cross—
Stoch %K / %D89 / 95
ADX (14)38
+DI / −DI46 / 13
RSI divergence—
MACD divergence—
ATR %+3.21%
ADR %3.63%
52w high17.30
52w low7.82
From 52w high+0.00%
Above 52w low+121.23%
New 52w highYes
SqueezeOff
Bollinger width42.73%
%B0.86
Donchian pos91.10%
Donchian high17.77
Donchian low12.49
AVWAP (52w high)17.43
vs AVWAP high-0.74%
AVWAP (52w low)12.48
vs AVWAP low+38.60%
OBV trendUp
Chaikin MF (20)0.13
Today vs 20d3.43×
Avg vol (14d)2.51M
Avg vol (20d)2.29M
Avg $ vol (20d)35.34M
Market cap5.52B
RS 3m (vs SPY)+30.83%
RS 6m (vs SPY)+29.65%
RS line new highYes
Trend template8/8
Technical rank92.1
1 week+6.27%
1 month+35.26%
3 months+41.11%
6 months+34.95%
1 year+112.79%
YTD+36.65%
P/E76.59
P/B-121.54
P/S1.83
P/FCF20.45
EPS0.2200
Div yield—
ROE-158.68%
ROA2.04%
Debt/Eq-56.63
Current2.47
EV/EBITDA—
Gross margin36.88%
Net margin2.39%
Rev growth8.05%
EPS growth161.65%
Price target16.67
Target upside-3.64%
Analyst ratingBuy
Institutional56.42%
Ent. value7.89B
Revenue722.52M
Net income62.26M
Gross profit320.11M
Free cash flow269.93M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out319.02M
Employees8.5K
ListedMon, May 7, 2018
Free float169.55M
Float %53.2%
Short interest7.53M
Days to cover4.6d
Short volume44.0%
Squeeze score50 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast$0.24 · 1 est
Last EPS vs est$0.26 vs $0.15
Last surprise+73.3% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank92.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance15.23
Support12.07
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in AMRX
No recent disclosed trades by Congress in AMRX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AMRX · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Autor Deborah M. Director · Class A Common Stock · 2026-05-11 | Sell | 34.82K | $451K | 2026-05-11 | 2026-05-12 |
Nark Ted C Director · Class A Common Stock · 2026-05-07 | Exercise | 34.82K | — | 2026-05-07 | 2026-05-08 |
BUCHI J KEVIN Director · Class A Common Stock · 2026-05-07 | Exercise | 34.82K | — | 2026-05-07 | 2026-05-08 |
George Jeffrey P. Director · Class A Common Stock · 2026-05-07 | Exercise | 34.82K | — | 2026-05-07 | 2026-05-08 |
MEISTER PAUL M Director · Restricted Stock Units · 2026-05-07 | Exercise | 48.75K | $0 | 2026-05-07 | 2026-05-08 |
Yanai Shlomo Director · Restricted Stock Units · 2026-05-07 | Exercise | 34.82K | $0 | 2026-05-07 | 2026-05-08 |
Kiely John Director · Restricted Stock Units · 2026-05-07 | Exercise | 34.82K | $0 | 2026-05-07 | 2026-05-08 |
Autor Deborah M. Director · Restricted Stock Units · 2026-05-07 | Exercise | 34.82K | $0 | 2026-05-07 | 2026-05-08 |
Patel Gautam Director · Restricted Stock Units · 2026-05-07 | Exercise | 34.82K | $0 | 2026-05-07 | 2026-05-08 |
Autor Deborah M. Director · Class A Common Stock · 2026-05-07 | Exercise | 34.82K | — | 2026-05-07 | 2026-05-08 |
SEC filings
EDGAR filings in AMRX · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.